Export-Reliant Indian Drug Industry Faces Fall Of Rupee Value
This article was originally published in PharmAsia News
Executive Summary
India's pharmaceutical industry is discovering it might not be as immune to the global financial crisis as previously believed. Indian pharmas normally would have been expected to continue reaping the rewards of drug exports still needed worldwide, but the value of the rupee has fallen enough to counterbalance any of those gains. Part of the negative impact is due to the fact the capital used to pay for products that India exports has to be weighed against the reduced value of the rupee. The situation means at least a temporary freeze on expansion through acquisitions and cutbacks of expenses by Indian drug makers. (Click here for more
You may also be interested in...
Economic Downturn May Hit Indian Drug Exports; Research Contracts May Dry Up
MUMBAI - Adverse economic conditions across several countries is likely to hit exports of Indian pharmaceutical companies for the current and the next year
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.
Metsera Launches As New Obesity Contender Flush With $290m
Clive Meanwell, former CEO of The Medicines Company, will helm the new company, backed by ARCH and other investors. He talked to Scrip about the new venture.